Publicacións nas que colabora con MANUEL FELIX CAMIÑA DARRIBA (29)

2023

  1. Prevalence and Risk Factors for Airflow Limitation in Patients With Acute Coronary Syndrome

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 397-400

2022

  1. At-admission HbA1c levels in hospitalized COVID-19 participants with and without known diabetes

    Clinica Chimica Acta, Vol. 532, pp. 188-192

  2. The oxyhaemoglobin dissociation curve is generally left-shifted in COVID-19 patients at admission to hospital, and this is associated with lower mortality

    British Journal of Haematology, Vol. 199, Núm. 3, pp. 332-338

2019

  1. Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1023-1030

2018

  1. Continuous glucose monitoring is more sensitive than HbA1c and fasting glucose in detecting dysglycaemia in a Spanish population without diabetes

    Diabetes Research and Clinical Practice, Vol. 142, pp. 100-109

2017

  1. Corrected Fructosamine improves both correlation with HbA1C and diagnostic performance

    Clinical Biochemistry, Vol. 50, Núm. 3, pp. 110-115

2016

  1. Impact of mean cell hemoglobin on Hb A1c-defined glycemia status

    Clinical Chemistry, Vol. 62, Núm. 12, pp. 1570-1578

2015

  1. Influence of the glycation gap on the diagnosis of type 2 diabetes

    Acta Diabetologica, Vol. 52, Núm. 3, pp. 453-459

2012

  1. Estimation of the glycation gap in diabetic patients with stable glycemic control

    Diabetes Care, Vol. 35, Núm. 12, pp. 2447-2450

  2. Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type2 diabetes

    Diabetic Medicine, Vol. 29, Núm. 12, pp. 1562-1566

2011

  1. Progression of nephropathy in type 2 diabetes: The glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c)

    Clinical Chemistry, Vol. 57, Núm. 2, pp. 264-271

2009

  1. Actualización en el laboratorio clínico, 2009

    Departamento de Bioquímica e Bioloxía Molecular

  2. Translating the A1C assay into estimated average glucose values

    Diabetes Care

2008

  1. Actualización en el laboratorio clínico, 2008

    Departamento de Bioquímica e Bioloxía Molecular

2007

  1. Tissue-polypeptide-specific antigen levels in diabetic patients with normal and pathological biochemical profiles

    Clinical Biochemistry, Vol. 40, Núm. 3-4, pp. 278-281

2006

  1. Treatment of Mitochondrial Encephalomyopathies With a Xanthine Oxidase Inhibitor

    Pediatric Neurology, Vol. 35, Núm. 5, pp. 318-322

2005

  1. Plasma albumin concentration is a predictor of HbA1c among type 2 diabetic patients, independently of fasting plasma glucose and fructosamine

    Diabetes Care, Vol. 28, Núm. 2, pp. 437-439

2003

  1. Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis

    Brain and Development, Vol. 25, Núm. 2, pp. 102-106

2001

  1. Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis

    Journal of Child Neurology, Vol. 16, Núm. 9, pp. 704-706

2000

  1. Cerebrospinal fluid purine metabolite and neuron-specific enolase concentrations after febrile seizures

    Brain and Development, Vol. 22, Núm. 7, pp. 427-431